These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7586718

  • 1. Superantigens in Kawasaki syndrome.
    Leung DY, Meissner HC, Fulton DR, Quimby F, Schlievert PM.
    Clin Immunol Immunopathol; 1995 Nov; 77(2):119-26. PubMed ID: 7586718
    [Abstract] [Full Text] [Related]

  • 2. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin.
    Leung DY.
    Clin Exp Immunol; 1996 May; 104 Suppl 1():49-54. PubMed ID: 8625544
    [Abstract] [Full Text] [Related]

  • 3. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.
    Leung DY, Meissner C, Fulton D, Schlievert PM.
    J Clin Immunol; 1995 Nov; 15(6 Suppl):11S-17S. PubMed ID: 8613483
    [Abstract] [Full Text] [Related]

  • 4. Kawasaki syndrome: role of superantigens revisited.
    Leung DYM, Schlievert PM.
    FEBS J; 2021 Mar; 288(6):1771-1777. PubMed ID: 32770775
    [Abstract] [Full Text] [Related]

  • 5. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome.
    Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB.
    J Immunol; 1995 Nov 15; 155(10):5018-21. PubMed ID: 7594509
    [Abstract] [Full Text] [Related]

  • 6. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease.
    Morita A, Imada Y, Igarashi H, Yutsudo T.
    Microbiol Immunol; 1997 Nov 15; 41(11):895-900. PubMed ID: 9444333
    [Abstract] [Full Text] [Related]

  • 7. Kawasaki disease: is it caused by an infectious agent?
    Lloyd AJ, Walker C, Wilkinso M.
    Br J Biomed Sci; 2001 Nov 15; 58(2):122-8. PubMed ID: 11440204
    [Abstract] [Full Text] [Related]

  • 8. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome.
    Yarwood JM, Leung DY, Schlievert PM.
    FEMS Microbiol Lett; 2000 Nov 01; 192(1):1-7. PubMed ID: 11040420
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a superantigen mediated process in Kawasaki disease.
    Curtis N, Zheng R, Lamb JR, Levin M.
    Arch Dis Child; 1995 Apr 01; 72(4):308-11. PubMed ID: 7763061
    [Abstract] [Full Text] [Related]

  • 10. Superantigens, conventional antigens and the etiology of Kawasaki syndrome.
    Meissner HC, Leung DY.
    Pediatr Infect Dis J; 2000 Feb 01; 19(2):91-4. PubMed ID: 10693992
    [No Abstract] [Full Text] [Related]

  • 11. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome.
    Nomura Y, Yoshinaga M, Masuda K, Takei S, Miyata K.
    J Infect Dis; 2002 Jun 01; 185(11):1677-80. PubMed ID: 12023778
    [Abstract] [Full Text] [Related]

  • 12. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
    Leung DY, Sullivan KE, Brown-Whitehorn TF, Fehringer AP, Allen S, Finkel TH, Washington RL, Makida R, Schlievert PM.
    Pediatr Res; 1997 Sep 01; 42(3):268-72. PubMed ID: 9284264
    [Abstract] [Full Text] [Related]

  • 13. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease.
    Matsubara K, Fukaya T.
    Curr Opin Infect Dis; 2007 Jun 01; 20(3):298-303. PubMed ID: 17471041
    [Abstract] [Full Text] [Related]

  • 14. Kawasaki disease: an update.
    Nasr I, Tometzki AJ, Schofield OM.
    Clin Exp Dermatol; 2001 Jan 01; 26(1):6-12. PubMed ID: 11260168
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease.
    Gupta-Malhotra M, Viteri-Jackson A, Thomas W, Zabriskie JB.
    Exp Mol Pathol; 2004 Apr 01; 76(2):117-21. PubMed ID: 15010289
    [Abstract] [Full Text] [Related]

  • 16. Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age.
    Nomura Y, Masuda K, Yoshinaga M, Takei S, Miyata K.
    Pediatr Infect Dis J; 2003 Sep 01; 22(9):794-8. PubMed ID: 14506370
    [Abstract] [Full Text] [Related]

  • 17. Twenty-five types of T-cell receptor Vbeta family repertoire in patients with Kawasaki syndrome.
    Nomura Y, Masuda K, Shinkoda Y, Sameshima K, Oku S, Yoshinaga M, Miyata K.
    Eur J Pediatr; 1998 Dec 01; 157(12):981-6. PubMed ID: 9877036
    [Abstract] [Full Text] [Related]

  • 18. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
    Marcinkiewicz J, Szymanowska Z, Mazurek A.
    Przegl Lek; 1998 Dec 01; 55(11):611-3. PubMed ID: 10216377
    [Abstract] [Full Text] [Related]

  • 19. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM.
    Lancet; 1993 Dec 04; 342(8884):1385-8. PubMed ID: 7901681
    [Abstract] [Full Text] [Related]

  • 20. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
    Matsubara K, Fukaya T, Miwa K, Shibayama N, Nigami H, Harigaya H, Nozaki H, Hirata T, Baba K, Suzuki T, Ishiguro A.
    Clin Exp Immunol; 2006 Mar 04; 143(3):427-34. PubMed ID: 16487241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.